Workflow
What's Going On With MannKind Stock Friday? - MannKind (NASDAQ:MNKD)
Benzinga· 2026-02-27 17:30
MannKind Corporation (NASDAQ:MNKD) reported its fourth-quarter and full-year 2025 financial results on Friday.The company reported fourth-quarter adjusted earnings per share of one cent, in line with the Street view. Quarterly sales of $111.955 million outpaced the Street view of $97.604 million.MannKind reported total revenues for the fourth quarter and full year 2025 rose due to increases in revenue from royalties, collaborations, and commercial product sales.The CEO highlighted the addition of Furoscix a ...
Revisiting Comparative Valuations In Light Of Nvidia's Earnings (Upgrade)
Seeking Alpha· 2026-02-27 17:30
Core Insights - NVIDIA Corporation reported a remarkable earnings increase for the period ending January 25, with revenue rising 73% year-over-year and earnings per share reaching $1.62, both exceeding expectations [1] - For the upcoming fiscal first quarter, NVIDIA anticipates revenue of approximately $78 billion, indicating strong future performance [1] Financial Performance - Revenue growth of 73% year-over-year highlights NVIDIA's robust market position and demand for its products [1] - Earnings per share of $1.62 surpassed analyst expectations, reflecting effective cost management and operational efficiency [1] Future Outlook - NVIDIA's forecast of approximately $78 billion in revenue for the next fiscal quarter suggests continued growth and confidence in market demand [1]
Thermon Group Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thermon Group Holdings, Inc. - THR
Businesswire· 2026-02-27 17:30
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-thr/ to learn more. NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Fo ...
Wall Street's Most Important Number Just Got Hit. That Isn't Good.
Barrons· 2026-02-27 17:30
Yields on 10-year Treasury notes fell below 4% for the first time since November this week. ...
INVESTOR DEADLINE: Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law
Globenewswire· 2026-02-27 17:30
Core Viewpoint - The Enphase Energy class action lawsuit alleges that the company and its executives made misleading statements regarding their financial and operational prospects, leading to significant stock price declines following the disclosure of negative financial results [3][4]. Group 1: Class Action Details - The class action lawsuit is titled Tripathi v. Enphase Energy, Inc., and it involves purchasers of Enphase Energy securities from April 22, 2025, to October 28, 2025 [1]. - Investors have until April 20, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit claims that Enphase Energy overstated its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit [3]. Group 2: Financial Impact - On October 28, 2025, Enphase Energy reported that elevated channel inventory would lead to lower battery storage shipments in Q4 2025 and that the expiration of the 25D Credit would negatively impact revenues in Q1 2026 [4]. - Following this announcement, Enphase Energy's stock price fell by more than 15% [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Enphase Energy securities during the class period to seek lead plaintiff status [5]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [6]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, including the largest securities class action recovery in history [6].
King Copper Discovery Reports on Key Technical Team Additions and Participation at Upcoming 2026 PDAC Core Shack
Globenewswire· 2026-02-27 17:30
Core Insights - King Copper Discovery Corp has announced key additions to its technical team to advance the Colquemayo Project in Peru and will participate in the upcoming PDAC conference in Toronto [1][6] Technical Team Additions - Mr. Fabio Cuoco has been appointed as Project Manager, bringing over 20 years of experience in mineral exploration, particularly in copper and porphyry copper systems, with a background at Rio Tinto and Vale Exploration Peru [2][9] - Mr. Javier Escudero has been appointed as Senior Advisor for Corporate and Social Affairs, with extensive experience in sustainable mining and community relations, having held key roles at Hudbay Peru S.A.C. and other global firms [4][5][9] PDAC Conference Participation - King Copper will participate in the 2026 PDAC Core Shack at Booth 3116A on March 1 and 2, showcasing drill core from a recent reinterpretation of approximately 20,000 meters of historical core in preparation for a fully financed 35,000-meter drill program [6][9] Project Overview - The Colquemayo Project covers 6,600 hectares with copper-gold-silver mineralization in high-sulphidation epithermal systems, featuring intense hydrothermal alteration mapped over an area of 12 km by 3 km [7] - Historic drill results include an intersection of 237.3 meters returning 2.4% copper, 0.08 grams per tonne gold, and 10 grams per tonne silver, with notable segments of 161.2 meters at 3.4% copper and 31.3 meters at 14.8% copper [10][8] Stock Options and RSUs - The Company's Board of Directors has approved the grant of 250,000 stock options at a price of $1.10 per common share for five years and 450,000 Restricted Share Units (RSUs) with a two-year vesting period [11]
How Trump's 'One Big Beautiful Bill' could force some older workers to delay retirement — ways to protect your savings
Yahoo Finance· 2026-02-27 17:30
Some workers who are approaching retirement may need to change their plans thanks to President Donald Trump’s “One Big Beautiful Bill” — including when they retire. Due to the introduction of new work requirements for Medicaid and the Supplemental Nutrition Assistance Program (SNAP), Americans may need to remain in the workforce longer to maintain much-needed access to health care and food stamps. Must Read The bill’s changes to Medicaid include mandatory work requirements for many individuals aged 19 ...
Hedge Fund and Insider Trading News: David Tepper, Steve Cohen, Ray Dalio, Brevan Howard, Millennium Management, Citadel Investment Group, Candel Therapeutics Inc (CADL), Meta Platforms Inc (META), an
Insider Monkey· 2026-02-27 17:29
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences. At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000 ...
Why Are Shares Of Xeris Biopharma Falling Friday?
Benzinga· 2026-02-27 17:29
Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) are falling Friday after the company announced a patent infringement lawsuit to protect its drug, Recorlev.Xeris Biopharma Holdings stock is taking a hit today. What’s weighing on XERS shares?Lawsuit Targets Two Pharmaceutical CompaniesThe lawsuit, filed by Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited, targets unauthorized generic versions of Recorlev. The lawsuit names Torrent Pharmaceuticals Limited and Somerset Therapeutics, LLC as the ...
JPMorgan, Barclays, Fifth Third sued by investors for missing 'giant red flags' at Tricolor
Reuters· 2026-02-27 17:29
Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv JPMorgan, Barclays, Fifth Third sued by investors for missing 'giant red flags' at Tricolor "Rather than risk a massive loss on their warehouse lines and forfeit the millions of dollars of fees and income derived from Tricolor's fraudulent enterprise, defendants responded by hiding what they had learned and sticking their heads in the sand," the complaint said. JPMorgan, Barclays and Cincinnat ...